Advertisement
Screener

HERON THERAPEUTICS, INC. /DE/ (HRTX) Weighted Average Number of Shares Outstanding, Basic and Diluted

HERON THERAPEUTICS, INC. /DE/ Weighted Average Number of Shares Outstanding, Basic and Diluted

HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 102.12 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09

  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 102.12M shares, a 11.75% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 102.01M shares, a 12.00% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 101.91M shares, a 12.17% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 98.46M shares, a 8.49% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 98.47M shares, a 8.48% increase from fiscal 2020.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 90.77M shares, a 11.00% increase from fiscal 2019.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 81.78M shares, a 11.73% increase from fiscal 2018.
  • HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 73.19M shares, a 35.44% increase from fiscal 2017.
Period endWeighted Average Number of Shares Outstanding, Basic and Diluted 3 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 6 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 9 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 12 month
2022-03-31102.12M shares
10-Q · filed 2022-05-09
102.07M shares
derived: average of 2 quarters · filed 2022-05-09
102.01M shares
derived: average of 3 quarters · filed 2022-05-09
101.13M shares
derived: average of 4 quarters · filed 2022-05-09
2021-12-31102.01M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
101.96M shares
derived: average of 2 quarters · filed 2022-02-28
100.79M shares
derived: average of 3 quarters · filed 2022-02-28
98.47M shares
10-K · filed 2022-02-28
2021-09-30101.91M shares
10-Q · filed 2021-11-03
100.18M shares
derived: average of 2 quarters · filed 2021-11-03
97.29M shares
10-Q · filed 2021-11-03
95.71M shares
derived: average of 4 quarters · filed 2022-05-09
2021-06-3098.46M shares
10-Q · filed 2021-08-09
94.94M shares
10-Q · filed 2021-08-09
93.64M shares
derived: average of 3 quarters · filed 2022-05-09
92.94M shares
derived: average of 4 quarters · filed 2022-05-09
2021-03-3191.39M shares
10-Q · filed 2022-05-09
91.24M shares
derived: average of 2 quarters · filed 2022-05-09
91.11M shares
derived: average of 3 quarters · filed 2022-05-09
91.02M shares
derived: average of 4 quarters · filed 2022-05-09
2020-12-3191.08M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
90.97M shares
derived: average of 2 quarters · filed 2022-02-28
90.89M shares
derived: average of 3 quarters · filed 2022-02-28
90.77M shares
10-K · filed 2022-02-28
2020-09-3090.85M shares
10-Q · filed 2021-11-03
90.80M shares
derived: average of 2 quarters · filed 2021-11-03
90.67M shares
10-Q · filed 2021-11-03
90.30M shares
derived: average of 4 quarters · filed 2022-02-28
2020-06-3090.75M shares
10-Q · filed 2021-08-09
90.58M shares
10-Q · filed 2021-08-09
90.12M shares
derived: average of 3 quarters · filed 2022-02-28
87.57M shares
derived: average of 4 quarters · filed 2022-02-28
2020-03-3190.41M shares
10-Q · filed 2021-05-10
89.80M shares
derived: average of 2 quarters · filed 2022-02-28
86.51M shares
derived: average of 3 quarters · filed 2022-02-28
84.77M shares
derived: average of 4 quarters · filed 2022-02-28
2019-12-3189.19M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
84.57M shares
derived: average of 2 quarters · filed 2022-02-28
82.89M shares
derived: average of 3 quarters · filed 2022-02-28
81.78M shares
10-K · filed 2022-02-28
2019-09-3079.94M shares
10-Q · filed 2020-11-05
79.74M shares
derived: average of 2 quarters · filed 2020-11-05
79.31M shares
10-Q · filed 2020-11-05
79.01M shares
derived: average of 4 quarters · filed 2021-02-24
2019-06-3079.55M shares
10-Q · filed 2020-08-05
78.99M shares
10-Q · filed 2020-08-05
78.70M shares
derived: average of 3 quarters · filed 2021-02-24
78.48M shares
derived: average of 4 quarters · filed 2021-02-24
2019-03-3178.42M shares
10-Q · filed 2020-05-06
78.28M shares
derived: average of 2 quarters · filed 2021-02-24
78.12M shares
derived: average of 3 quarters · filed 2021-02-24
76.58M shares
derived: average of 4 quarters · filed 2021-02-24
2018-12-3178.14M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
77.98M shares
derived: average of 2 quarters · filed 2021-02-24
75.97M shares
derived: average of 3 quarters · filed 2021-02-24
73.19M shares
10-K · filed 2021-02-24
2018-09-3077.81M shares
10-Q · filed 2019-11-12
74.88M shares
derived: average of 2 quarters · filed 2019-11-12
71.54M shares
10-Q · filed 2019-11-12
68.03M shares
derived: average of 4 quarters · filed 2020-03-02
2018-06-3071.95M shares
10-Q · filed 2019-08-05
68.36M shares
10-Q · filed 2019-08-05
64.77M shares
derived: average of 3 quarters · filed 2020-03-02
62.12M shares
derived: average of 4 quarters · filed 2020-03-02
2018-03-3164.72M shares
10-Q · filed 2019-05-09
61.17M shares
derived: average of 2 quarters · filed 2020-03-02
58.84M shares
derived: average of 3 quarters · filed 2020-03-02
57.58M shares
derived: average of 4 quarters · filed 2020-03-02
2017-12-3157.62M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
55.90M shares
derived: average of 2 quarters · filed 2020-03-02
55.20M shares
derived: average of 3 quarters · filed 2020-03-02
54.04M shares
10-K · filed 2020-03-02
2017-09-3054.18M shares
10-Q · filed 2018-11-07
53.98M shares
derived: average of 2 quarters · filed 2018-11-07
52.85M shares
10-Q · filed 2018-11-07
49.45M shares
derived: average of 4 quarters · filed 2019-02-22
2017-06-3053.79M shares
10-Q · filed 2018-08-08
52.17M shares
10-Q · filed 2018-08-08
47.87M shares
derived: average of 3 quarters · filed 2019-02-22
45.68M shares
derived: average of 4 quarters · filed 2019-02-22
2017-03-3150.53M shares
10-Q · filed 2018-05-10
44.91M shares
derived: average of 2 quarters · filed 2019-02-22
42.98M shares
derived: average of 3 quarters · filed 2019-02-22
41.50M shares
derived: average of 4 quarters · filed 2019-02-22
2016-12-3139.29M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
39.20M shares
derived: average of 2 quarters · filed 2019-02-22
38.48M shares
derived: average of 3 quarters · filed 2019-02-22
37.92M shares
10-K · filed 2019-02-22
2016-09-3039.11M shares
10-Q · filed 2017-11-06
38.08M shares
derived: average of 2 quarters · filed 2017-11-06
37.47M shares
10-Q · filed 2017-11-06
37.11M shares
derived: average of 4 quarters · filed 2018-02-27
2016-06-3037.05M shares
10-Q · filed 2017-08-09
36.64M shares
10-Q · filed 2017-08-09
36.44M shares
derived: average of 3 quarters · filed 2018-02-27
36.28M shares
derived: average of 4 quarters · filed 2018-02-27
2016-03-3136.23M shares
10-Q · filed 2017-05-10
36.14M shares
derived: average of 2 quarters · filed 2018-02-27
36.02M shares
derived: average of 3 quarters · filed 2018-02-27
34.77M shares
derived: average of 4 quarters · filed 2018-02-27
2015-12-3136.05M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
35.91M shares
derived: average of 2 quarters · filed 2018-02-27
34.29M shares
derived: average of 3 quarters · filed 2018-02-27
33.08M shares
10-K · filed 2018-02-27
2015-09-3035.77M shares
10-Q · filed 2016-11-08
33.40M shares
derived: average of 2 quarters · filed 2016-11-08
32.09M shares
10-Q · filed 2016-11-08
31.36M shares
derived: average of 4 quarters · filed 2017-02-23
2015-06-3031.04M shares
10-Q · filed 2016-08-08
30.22M shares
10-Q · filed 2016-08-08
29.89M shares
derived: average of 3 quarters · filed 2017-02-23
29.67M shares
derived: average of 4 quarters · filed 2017-02-23
2015-03-3129.39M shares
10-Q · filed 2016-05-05
29.32M shares
derived: average of 2 quarters · filed 2017-02-23
29.21M shares
derived: average of 3 quarters · filed 2017-02-23
27.98M shares
derived: average of 4 quarters · filed 2017-02-23
2014-12-3129.24M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
29.12M shares
derived: average of 2 quarters · filed 2017-02-23
27.50M shares
derived: average of 3 quarters · filed 2017-02-23
26.57M shares
10-K · filed 2017-02-23
2014-09-3029.00M shares
10-Q · filed 2015-11-06
26.64M shares
derived: average of 2 quarters · filed 2015-11-06
25.68M shares
10-Q · filed 2015-11-06
23.92M shares
derived: average of 4 quarters · filed 2016-02-19
2014-06-3024.27M shares
10-Q · filed 2015-08-07
23.99M shares
10-Q · filed 2015-08-07
22.23M shares
derived: average of 3 quarters · filed 2016-02-19
20.52M shares
derived: average of 4 quarters · filed 2016-02-19
2014-03-3123.69M shares
10-Q · filed 2015-05-08
21.21M shares
derived: average of 2 quarters · filed 2016-02-19
19.27M shares
derived: average of 3 quarters · filed 2016-02-19
18.27M shares
derived: average of 4 quarters · filed 2016-02-19
2013-12-3118.74M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
17.06M shares
derived: average of 2 quarters · filed 2016-02-19
16.47M shares
derived: average of 3 quarters · filed 2016-02-19
16.16M shares
10-K · filed 2016-02-19
2013-09-3015.38M shares
10-Q · filed 2014-11-06
307.50M shares
10-Q · filed 2013-11-12
15.33M shares
derived: average of 2 quarters · filed 2014-11-06
15.30M shares
10-Q · filed 2014-11-06
306.10M shares
10-Q · filed 2013-11-12
-145.10M shares
derived: average of 4 quarters · filed 2015-03-13
2013-06-3015.29M shares
10-Q · filed 2014-08-04
305.69K shares
10-Q · filed 2013-08-08
15.27M shares
10-Q · filed 2014-08-04
305.38K shares
10-Q · filed 2013-08-08
-198.59M shares
derived: average of 3 quarters · filed 2015-03-13
-80.32M shares
derived: average of 4 quarters · filed 2015-03-13
2013-03-3115.25M shares
10-Q · filed 2014-05-12
305.07M shares
10-Q · filed 2013-05-10
-305.52M shares
derived: average of 2 quarters · filed 2015-03-13
-112.19M shares
derived: average of 3 quarters · filed 2015-03-13
-84.09M shares
derived: average of 4 quarters · filed 2015-03-13
2012-12-31-626.30M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
-175.90M shares
derived: average of 2 quarters · filed 2015-03-13
-117.20M shares
derived: average of 3 quarters · filed 2015-03-13
12.22M shares
10-K · filed 2015-03-13
2012-09-30274.49M shares
10-Q · filed 2013-11-12
137.34M shares
derived: average of 2 quarters · filed 2013-11-12
225.06M shares
10-Q · filed 2013-11-12
2012-06-30200.11K shares
10-Q · filed 2013-08-08
200.08K shares
10-Q · filed 2013-08-08
2012-03-31200.05M shares
10-Q · filed 2013-05-10
2011-12-316.01M shares
10-K · filed 2014-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
Xilio Therapeutics, Inc. (XLO)United States$0.052B
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
TALPHERA, INC. (TLPH)United States$0.060B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Lite Strategy, Inc. (LITS)United States$0.049B